VICRYL Polyglactin 910 Synthetic Absorbable Sutures - Suture, polyglactin

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Commercializzato da:

Johnson & Johnson Medical Pty Ltd

Classe:

Class III

Prodotto da:

Johnson & Johnson International c/o European Logistics Centre, Leonardo Da Vincilaan 15, Diegem, BE-1831 Belgium

Area terapeutica:

17471 - Suture, polyglactin

Indicazioni terapeutiche:

Coated,absorbable, sterile, surgical suture composed of a copolymer made from 90% glycoside and 10% L-lactide. Available undyed natural and dyed violet to enhance visibility in tissue. Available with or without needles. VICRYL sutures are intended for use in general soft tissue approximation and/or ligation, including use in ophthalmic surgery, peripheral nerve anastomosis and microsurgery for vessels less than 2 mm diameter. Not to be used in cardiovascular surgery.

Stato dell'autorizzazione:

A

Data dell'autorizzazione:

2007-02-16